|
1
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lauressergues D, Couzigou JM, Clemente HS,
Martinez Y, Dunand C, Becard G and Combier JP: Primary transcripts
of microRNAs encode regulatory peptides. Nature. 520:90–93. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Voinnet O: Origin, biogenesis, and
activity of plant microRNAs. Cell. 136:669–687. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Di Giacomo G, Koss M, Capellini TD,
Brendolan A, Popperl H and Selleri L: Spatio-temporal expression of
Pbx3 during mouse organogenesis. Gene Expr Patterns. 6:747–757.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lichtenauer UD, Duchniewicz M, Kolanczyk
M, Hoeflich A, Hahner S, Else T, Bicknell AB, Zemojtel T, Stallings
NR, Schulte DM, et al: Pre-B-cell transcription factor 1 and
steroidogenic factor 1 synergistically regulate adrenocortical
growth and steroidogenesis. Endocrinology. 148:693–704. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu C, Chen Z, Hu X, Wang L, Li C, Xue J,
Zhang P, Chen W and Jiang A: MicroRNA-185 downregulates androgen
receptor expression in the LNCaP prostate carcinoma cell line. Mol
Med Rep. 11:4625–4632. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takahashi Y, Forrest AR, Maeno E,
Hashimoto T, Daub CO and Yasuda J: miR-107 and miR-185 can induce
cell cycle arrest in human non small cell lung cancer cell lines.
PLoS One. 18:e66772009. View Article : Google Scholar
|
|
8
|
Imam JS, Buddavarapu K, Lee-Chang JS,
Ganapathy S, Camosy C, Chen Y and Rao MK: MicroRNA-185 suppresses
tumor growth and progression by targeting the Six1 oncogene in
human cancers. Oncogene. 29:4971–4979. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Akçakaya P, Ekelund S, Kolosenko I,
Caramuta S, Ozata DM, Xie H, Lindforss U, Olivecrona H and Lui WO:
miR-185 and miR-133b deregulation is associated with overall
survival and metastasis in colorectal cancer. Int J Oncol.
39:311–318. 2011.PubMed/NCBI
|
|
10
|
Lu ZJ, Lu LG, Tao KZ, Chen DF, Xia Q, Weng
JJ, Zhu F, Wang XP and Zheng P: MicroRNA-185 suppresses growth and
invasion of colon cancer cells through inhibition of the
hypoxiainducible factor-2alpha pathway in vitro and in vivo. Mol
Med Rep. 10:2401–2408. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu M, Lang N, Chen X, Tang Q, Liu S,
Huang J, Zheng Y and Bi F: miR-185 targets RhoA and Cdc42
expression and inhibits the proliferation potential of human
colorectal cells. Cancer Lett. 301:151–160. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhu X, Li Y, Shen H, Li H, Long L, Hui L
and Xu W: miR-137 inhibits the proliferation of lung cancer cells
by targeting Cdc42 and Cdk6. FEBS Lett. 587:73–81. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu M, Lang N, Qiu M, Xu F, Li Q, Tang Q,
Chen J, Chen X, Zhang S, Liu Z, et al: miR-137 targets Cdc42
expression, induces cell cycle G1 arrest and inhibits invasion in
colorectal cancer cells. Int J Cancer. 128:1269–1279. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fritz G, Just I and Kaina B: Rho GTPases
are over-expressed in human tumors. Int J Cancer. 81:682–687. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zegers MM and Friedl P: Rho GTPases in
collective cell migration. Small GTPases. 5:e289972014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Arias-Romero LE and Chernoff J: Targeting
Cdc42 in cancer. Expert Opin Ther Targets. 17:1263–1273. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stengel K and Zheng Y: Cdc42 in oncogenic
transformation, invasion, and tumorigenesis. Cell Signal.
23:1415–1423. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang L, Wang L and Zheng Y: Gene targeting
of Cdc42 and Cdc42GAP affirms the critical involvement of Cdc42 in
filopodia induction, directed migration, and proliferation in
primary mouse embryonic fibroblasts. Mol Biol Cell. 17:4675–4685.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chang CS, Huang SM, Lin HH, Wu CC and Wang
CJ: Different expression of apoptotic proteins between HBV-infected
and non-HBV-infected hepatocellular carcinoma.
Hepatogastroenterology. 54:2061–2068. 2007.PubMed/NCBI
|
|
20
|
Cooper AB, Wu J, Lu D and Maluccio MA: Is
autotaxin (ENPP2) the link between hepatitis C and hepatocellular
cancer? J Gastrointest Surg. 11:1628–1634. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Porta C, Larghi P, Rimoldi M, Totaro MG,
Allavena P, Mantovani A and Sica A: Cellular and molecular pathways
linking inflammation and cancer. Immunobiology. 214:761–777. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Iorio MV and Croce CM: MicroRNAs in
cancer: Small molecules with a huge impact. J Clin Oncol.
27:5848–5856. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jiang C, Chen X, Alattar M, Wei J and Liu
H: MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis
of gastric cancer. Cancer Gene Ther. 22:291–301. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Duan J, Zhang H, Qu Y, Deng T, Huang D,
Liu R, Zhang L, Bai M, Zhou L, Ying G, et al: Onco-miR-130 promotes
cell proliferation and migration by targeting TGFbetaR2 in gastric
cancer. Oncotarget. 7:44522–44533. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fabbri M, Garzon R, Cimmino A, Liu Z,
Zanesi N, Callegari E, Liu S, Alder H, Costinean S,
Fernandez-Cymering C, et al: MicroRNA-29 family reverts aberrant
methylation in lung cancer by targeting DNA methyltransferases 3A
and 3B. Proc Natl Acad Sci USA. 104:15805–15810. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
He L, Thomson JM, Hemann MT,
Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe
SW, Hannon GJ, et al: A microRNA polycistron as a potential human
oncogene. Nature. 435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tang H, Wang Z, Liu X, Liu Q, Xu G, Li G
and Wu M: LRRC4 inhibits glioma cell growth and invasion through a
miR-185-dependent pathway. Curr Cancer Drug Targets. 12:1032–1042.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xiang Y, Ma N, Wang D, Zhang Y, Zhou J, Wu
G, Zhao R, Huang H, Wang X, Qiao Y, et al: miR-152 and miR-185
co-contribute to ovarian cancer cells cisplatin sensitivity by
targeting DNMT1 directly: a novel epigenetic therapy independent of
decitabine. Oncogene. 33:378–386. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li S, Ma Y, Hou X, Liu Y, Li K, Xu S and
Wang J: miR-185 acts as a tumor suppressor by targeting AKT1 in
non-small cell lung cancer cells. Int J Clin Exp Pathol.
8:11854–11862. 2015.PubMed/NCBI
|
|
32
|
Xu Y, Qi Y, Luo J, Yang J, Xie Q, Deng C,
Su N, Wei W, Shi D, Xu F, et al: Hepatitis B virus X protein
stimulates proliferation, wound closure and inhibits apoptosis of
HuH-7 cells via CDC42. Int J Mol Sci. 18:e5862017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sharma P, Saini N and Sharma R: miR-107
functions as a tumor suppressor in human esophageal squamous cell
carcinoma and targets Cdc42. Oncol Rep. 37:3116–3127. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang C, Liu F, Chen H, Li N, Luo Z, Guo
W, Huang D, Tang S, Wang H, Cheng S, et al: Bif-1 promotes tumor
cell migration and metastasis via Cdc42 expression and activity.
Clin Exp Metastasis. 34:11–23. 2017. View Article : Google Scholar : PubMed/NCBI
|
